Edgewise Therapeutics, Inc. (EWTX) Earnings
Edgewise Therapeutics, Inc. is expected to report next earnings on November 5, 2026 (in NaN days), with a consensus EPS estimate of $-0.55. EWTX has beaten EPS estimates in 7 of its last 12 reported quarters (average surprise -4.1% over the last four).
Next earnings
Nov 5, 2026in NaN days
EPS est $-0.55 · Revenue est $129M
Track record
Beat EPS in 7 of 12 quarters
Avg surprise -4.1% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 6, 2026 | $-0.47 | $-0.53 | -13.3% | — | — |
| May 7, 2026 | $-0.50 | $-0.46 | +8.0% | — | — |
| Feb 26, 2026 | $-0.43 | $-0.49 | -13.5% | — | — |
| Nov 6, 2025 | $-0.40 | $-0.39 | +2.5% | — | — |
| Aug 7, 2025 | $-0.42 | $-0.34 | +19.0% | — | — |
| May 8, 2025 | $-0.45 | $-0.43 | +4.4% | — | — |
| Mar 3, 2025 | $-0.39 | $-0.42 | -7.7% | — | — |
| Nov 7, 2024 | $-0.37 | $-0.36 | +2.7% | — | — |
| Aug 8, 2024 | $-0.36 | $-0.34 | +5.6% | — | — |
| May 9, 2024 | $-0.39 | $-0.33 | +15.4% | — | — |
| Feb 22, 2024 | $-0.44 | $-0.47 | -6.8% | $2M | — |
| Nov 9, 2023 | $-0.40 | $-0.41 | -2.5% | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.